Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keenova Therapeutics
Dublin, Irelandkeenova.com ↗
- Ownership
- Private
- Employees
- ~1600
- Development stage
- Other
01
Overview
Keenova Therapeutics is a commercial-stage specialty pharmaceutical company focusing on branded therapies for rare and unaddressed medical conditions. The company has established marketed products including Acthar Gel for inflammatory and autoimmune conditions and XIAFLEX for Dupuytren's contracture and Peyronie's disease.
- Therapeutic areas
- EndocrinologyImmunologyRheumatologyMen's Health
- Modalities
- BiologicSmall molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Keenova Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Keenova Therapeutics.